Global Next Generation Sequencing Market Insights, Forecast to 2029

Publication ID:

PB503239090

Publication Date:

March 28, 2023

Pages:

106

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.
Market Analysis and Insights: Global Next Generation Sequencing Market
The global Next Generation Sequencing market is projected to grow from US$ 3834.5 million in 2023 to US$ 4686.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.
Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.
North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.
Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.
Report Includes
This report presents an overview of global market for Next Generation Sequencing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Next Generation Sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next Generation Sequencing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Next Generation Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Next Generation Sequencing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including 454 Life Sciences Corporation (A Roche Company), Agilent Technologies, Biomatters, Ltd, CLC Bio, GATC biotech AG, Macrogen, BGI (Beijing Genomics Institute), Illumina and Life Technology Corporation, etc.
By Company
454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar
Segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segment by Application
Whole-genome Sequencing
Exome Sequencing
Targeted Resequencing
De Novo Sequencing
RNA Sequencing
ChIP Sequencing
Methyl Sequencing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Next Generation Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencing companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation Sequencing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Sequencing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Targeted Sequencing & Resequencing
1.2.3 Whole Genome Sequencing
1.2.4 Whole Exome Sequencing
1.3 Market by Application
1.3.1 Global Next Generation Sequencing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Whole-genome Sequencing
1.3.3 Exome Sequencing
1.3.4 Targeted Resequencing
1.3.5 De Novo Sequencing
1.3.6 RNA Sequencing
1.3.7 ChIP Sequencing
1.3.8 Methyl Sequencing
1.3.9 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing Market Perspective (2018-2029)
2.2 Global Next Generation Sequencing Growth Trends by Region
2.2.1 Next Generation Sequencing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Next Generation Sequencing Historic Market Size by Region (2018-2023)
2.2.3 Next Generation Sequencing Forecasted Market Size by Region (2024-2029)
2.3 Next Generation Sequencing Market Dynamics
2.3.1 Next Generation Sequencing Industry Trends
2.3.2 Next Generation Sequencing Market Drivers
2.3.3 Next Generation Sequencing Market Challenges
2.3.4 Next Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Next Generation Sequencing by Players
3.1.1 Global Next Generation Sequencing Revenue by Players (2018-2023)
3.1.2 Global Next Generation Sequencing Revenue Market Share by Players (2018-2023)
3.2 Global Next Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Next Generation Sequencing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Next Generation Sequencing Market Concentration Ratio
3.4.1 Global Next Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Revenue in 2022
3.5 Global Key Players of Next Generation Sequencing Head office and Area Served
3.6 Global Key Players of Next Generation Sequencing, Product and Application
3.7 Global Key Players of Next Generation Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing Breakdown Data by Type
4.1 Global Next Generation Sequencing Historic Market Size by Type (2018-2023)
4.2 Global Next Generation Sequencing Forecasted Market Size by Type (2024-2029)
5 Next Generation Sequencing Breakdown Data by Application
5.1 Global Next Generation Sequencing Historic Market Size by Application (2018-2023)
5.2 Global Next Generation Sequencing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Next Generation Sequencing Market Size (2018-2029)
6.2 North America Next Generation Sequencing Market Size by Type
6.2.1 North America Next Generation Sequencing Market Size by Type (2018-2023)
6.2.2 North America Next Generation Sequencing Market Size by Type (2024-2029)
6.2.3 North America Next Generation Sequencing Market Share by Type (2018-2029)
6.3 North America Next Generation Sequencing Market Size by Application
6.3.1 North America Next Generation Sequencing Market Size by Application (2018-2023)
6.3.2 North America Next Generation Sequencing Market Size by Application (2024-2029)
6.3.3 North America Next Generation Sequencing Market Share by Application (2018-2029)
6.4 North America Next Generation Sequencing Market Size by Country
6.4.1 North America Next Generation Sequencing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Next Generation Sequencing Market Size by Country (2018-2023)
6.4.3 North America Next Generation Sequencing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Next Generation Sequencing Market Size (2018-2029)
7.2 Europe Next Generation Sequencing Market Size by Type
7.2.1 Europe Next Generation Sequencing Market Size by Type (2018-2023)
7.2.2 Europe Next Generation Sequencing Market Size by Type (2024-2029)
7.2.3 Europe Next Generation Sequencing Market Share by Type (2018-2029)
7.3 Europe Next Generation Sequencing Market Size by Application
7.3.1 Europe Next Generation Sequencing Market Size by Application (2018-2023)
7.3.2 Europe Next Generation Sequencing Market Size by Application (2024-2029)
7.3.3 Europe Next Generation Sequencing Market Share by Application (2018-2029)
7.4 Europe Next Generation Sequencing Market Size by Country
7.4.1 Europe Next Generation Sequencing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Next Generation Sequencing Market Size by Country (2018-2023)
7.4.3 Europe Next Generation Sequencing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Next Generation Sequencing Market Size (2018-2029)
8.2 China Next Generation Sequencing Market Size by Type
8.2.1 China Next Generation Sequencing Market Size by Type (2018-2023)
8.2.2 China Next Generation Sequencing Market Size by Type (2024-2029)
8.2.3 China Next Generation Sequencing Market Share by Type (2018-2029)
8.3 China Next Generation Sequencing Market Size by Application
8.3.1 China Next Generation Sequencing Market Size by Application (2018-2023)
8.3.2 China Next Generation Sequencing Market Size by Application (2024-2029)
8.3.3 China Next Generation Sequencing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Next Generation Sequencing Market Size (2018-2029)
9.2 Asia Next Generation Sequencing Market Size by Type
9.2.1 Asia Next Generation Sequencing Market Size by Type (2018-2023)
9.2.2 Asia Next Generation Sequencing Market Size by Type (2024-2029)
9.2.3 Asia Next Generation Sequencing Market Share by Type (2018-2029)
9.3 Asia Next Generation Sequencing Market Size by Application
9.3.1 Asia Next Generation Sequencing Market Size by Application (2018-2023)
9.3.2 Asia Next Generation Sequencing Market Size by Application (2024-2029)
9.3.3 Asia Next Generation Sequencing Market Share by Application (2018-2029)
9.4 Asia Next Generation Sequencing Market Size by Region
9.4.1 Asia Next Generation Sequencing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Next Generation Sequencing Market Size by Region (2018-2023)
9.4.3 Asia Next Generation Sequencing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Next Generation Sequencing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Next Generation Sequencing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Next Generation Sequencing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Next Generation Sequencing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 454 Life Sciences Corporation (A Roche Company)
11.1.1 454 Life Sciences Corporation (A Roche Company) Company Details
11.1.2 454 Life Sciences Corporation (A Roche Company) Business Overview
11.1.3 454 Life Sciences Corporation (A Roche Company) Next Generation Sequencing Introduction
11.1.4 454 Life Sciences Corporation (A Roche Company) Revenue in Next Generation Sequencing Business (2018-2023)
11.1.5 454 Life Sciences Corporation (A Roche Company) Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Next Generation Sequencing Introduction
11.2.4 Agilent Technologies Revenue in Next Generation Sequencing Business (2018-2023)
11.2.5 Agilent Technologies Recent Developments
11.3 Biomatters, Ltd
11.3.1 Biomatters, Ltd Company Details
11.3.2 Biomatters, Ltd Business Overview
11.3.3 Biomatters, Ltd Next Generation Sequencing Introduction
11.3.4 Biomatters, Ltd Revenue in Next Generation Sequencing Business (2018-2023)
11.3.5 Biomatters, Ltd Recent Developments
11.4 CLC Bio
11.4.1 CLC Bio Company Details
11.4.2 CLC Bio Business Overview
11.4.3 CLC Bio Next Generation Sequencing Introduction
11.4.4 CLC Bio Revenue in Next Generation Sequencing Business (2018-2023)
11.4.5 CLC Bio Recent Developments
11.5 GATC biotech AG
11.5.1 GATC biotech AG Company Details
11.5.2 GATC biotech AG Business Overview
11.5.3 GATC biotech AG Next Generation Sequencing Introduction
11.5.4 GATC biotech AG Revenue in Next Generation Sequencing Business (2018-2023)
11.5.5 GATC biotech AG Recent Developments
11.6 Macrogen
11.6.1 Macrogen Company Details
11.6.2 Macrogen Business Overview
11.6.3 Macrogen Next Generation Sequencing Introduction
11.6.4 Macrogen Revenue in Next Generation Sequencing Business (2018-2023)
11.6.5 Macrogen Recent Developments
11.7 BGI (Beijing Genomics Institute)
11.7.1 BGI (Beijing Genomics Institute) Company Details
11.7.2 BGI (Beijing Genomics Institute) Business Overview
11.7.3 BGI (Beijing Genomics Institute) Next Generation Sequencing Introduction
11.7.4 BGI (Beijing Genomics Institute) Revenue in Next Generation Sequencing Business (2018-2023)
11.7.5 BGI (Beijing Genomics Institute) Recent Developments
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Next Generation Sequencing Introduction
11.8.4 Illumina Revenue in Next Generation Sequencing Business (2018-2023)
11.8.5 Illumina Recent Developments
11.9 Life Technology Corporation
11.9.1 Life Technology Corporation Company Details
11.9.2 Life Technology Corporation Business Overview
11.9.3 Life Technology Corporation Next Generation Sequencing Introduction
11.9.4 Life Technology Corporation Revenue in Next Generation Sequencing Business (2018-2023)
11.9.5 Life Technology Corporation Recent Developments
11.10 EMC Corporation
11.10.1 EMC Corporation Company Details
11.10.2 EMC Corporation Business Overview
11.10.3 EMC Corporation Next Generation Sequencing Introduction
11.10.4 EMC Corporation Revenue in Next Generation Sequencing Business (2018-2023)
11.10.5 EMC Corporation Recent Developments
11.11 Dnastar
11.11.1 Dnastar Company Details
11.11.2 Dnastar Business Overview
11.11.3 Dnastar Next Generation Sequencing Introduction
11.11.4 Dnastar Revenue in Next Generation Sequencing Business (2018-2023)
11.11.5 Dnastar Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

454 Life Sciences Corporation (A Roche Company)
Agilent Technologies
Biomatters, Ltd
CLC Bio
GATC biotech AG
Macrogen
BGI (Beijing Genomics Institute)
Illumina
Life Technology Corporation
EMC Corporation
Dnastar

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂